US8871945B2 - Process for preparation of rufinamide - Google Patents

Process for preparation of rufinamide Download PDF

Info

Publication number
US8871945B2
US8871945B2 US13/818,660 US201113818660A US8871945B2 US 8871945 B2 US8871945 B2 US 8871945B2 US 201113818660 A US201113818660 A US 201113818660A US 8871945 B2 US8871945 B2 US 8871945B2
Authority
US
United States
Prior art keywords
formula
rufinamide
methyl
process according
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US13/818,660
Other versions
US20130184469A1 (en
Inventor
Ramamohan Rao Davuluri
Ravi Ponnaiah
Sanjay Kumar Dehury
Selvaraju K.
Deepthi VPSS
Dhanunjaya Naidu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of US20130184469A1 publication Critical patent/US20130184469A1/en
Application granted granted Critical
Publication of US8871945B2 publication Critical patent/US8871945B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/061,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/58Preparation of carboxylic acid halides
    • C07C51/60Preparation of carboxylic acid halides by conversion of carboxylic acids or their anhydrides or esters, lactones, salts into halides with the same carboxylic acid part
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/307Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles

Definitions

  • the invention provides a novel, industrially viable, cost effective process for manufacturing methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate a key intermediate in the synthesis of Rufinamide.
  • Rufinamide 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide commonly known as Rufinamide (Formula I) is triazole derivative and is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children 4 years and older and adults. Nicoinamide exerts its antiepileptic effect is unknown.
  • Rufinamide ( ⁇ 1 ⁇ M) significantly slowed sodium channel recovery from inactivation after a prolonged prepulse in cultured cortical neurons, and limited sustained repetitive firing of sodium-dependent action potentials (EC50 of 3.8 ⁇ M).
  • the process comprises the preparation of Rufinamide by reacting 2,6-difluorobenzyl chloride and sodium azide in the presence of DMSO to obtain 2,6-difluoro benzyl azide, which is then treated with propiolic acid to give carboxylic acid intermediate which on further reaction with thionyl chloride to give corresponding acyl chloride.
  • the acyl chloride intermediate is further reacted with methanolic ammonia to yield Rufinamide.
  • WO 2010/043849 describes the process for the preparation of Rufinamide as shown in scheme III below, which comprises the reaction of 2-(azidomethyl)-1, 3-difluorobenzene with methyl propiolate to obtain methyl 1-(2,6-difluorobenzyl)-1H-1,2,3,-triazole-4-carboxylate and which is reacted with ammonia to yield Rufinamide.
  • the object of the invention is to provide a novel process for the preparation of Rufinamide.
  • Another object of the present invention is to provide a process for the preparation of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate ester of formula VI, a key intermediate in the preparation of Rufinamide.
  • Yet another object of the invention is to provide a process for the bromination of alkyl acrylate of formula IV to obtain alkyl 2-bromoacrylate of formula V which is being used in the present synthesis of Rufinamide.
  • 2-(halomethyl)-1,3-difluorobenzene of formula II, wherein X is Cl, Br or I with an alkali metal azide reagent.
  • the alkali metal azide may be selected from sodium azide, potassium azide; preferably the alkali metal azide is sodium azide.
  • the reaction is carried out in a polar solvent selected from the group consisting of DMSO, DMF, t-butanol, preferably t-butanol to give the compound of the formula III.
  • 2-(bromomethyl)-1,3-difluorobenzene is treated with sodium azide in t-butanol to obtain 2-(azidomethyl)-1,3- difluorobenzyl of formula III.
  • the invention relates in particular to the preparation of compound of formula VI in which R is hydrogen, methyl or ethyl by treating corresponding acrylates compound of formula V such as 2-bromoacrylic acid, methyl 2-bromoacrylate or ethyl 2-bromoacrylate with azide compound of formula III.
  • the invention relates primarily to the preparation of methyl 1-(2, 6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate of formula VI.
  • the condensation of the azide compound of formula III with formula V is carried out in suitable polar protic solvent selected from the group consisting of acetic acid, methanol, formic acid, isopropanol, water and the like and mixtures thereof.
  • suitable polar protic solvent selected from the group consisting of acetic acid, methanol, formic acid, isopropanol, water and the like and mixtures thereof.
  • the said reaction is carried out preferably in water or tert-butanol or mixtures thereof to give the compound of the formula VI.
  • 2-(azidomethyl)-1,3- difluorobenzene is treated with methyl 2-bromoacrylate in mixture of t-butanol and water to produce methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate.
  • the 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate ester, where R is C1-C6 alkyl, of formula VI can be directly converted to Rufinamide by treatment with ammonia or by other methods known in the prior art.
  • the conversion can also be proceeded through 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylic acid intermediate, which in turn produced by hydrolysis of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate ester with alkali metal hydroxide.
  • methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate ester is hydrolysed in presence of aq. NaOH solution or NaOH flakes followed by acidification with HCl gives 1-(2,6-diflurobenzyl)-1H -1,2,3-triazole-4-carboxylic acid compound of formula VII.
  • the present invention also provides process for the preparation of 2-bromoacrylate of formula V, which comprises brominating acrylate of formula IV in presence of a brominating agent followed by treatment with base.
  • the invention relates in particular to the preparation of compound of formula V in which R is hydrogen, methyl or ethyl by brominating acrylic acid, methyl acrylate or ethyl acrylate of formula IV in presence of brominating agent.
  • the invention relates primarily to the preparation of compound of formula V in which R is methyl by brominating methyl acrylate.
  • the bromination reaction can be carried out in presence of a reagent selected from the group consisting of phosphorus tribromide, aluminum tribromide, bromine and the like; in suitable aprotic solvent selected from the group consisting of THF, acetone, acetonitrile and MDC and the like.
  • the base used in the bromination reaction is selected from the group consisting of sodium bicarbonate, potassium carbonate, potassium bicarbonate, potassium tert-butoxide, triethyl amine; preferably sodium carbonate and triethylamine, to give compound of the formula V.
  • methyl acrylate is brominated in presence of bromine and sodium carbonate in methylene chloride solvent to produce methyl 2-bromoacrylate.
  • Methyl acrylate (100 g) and methylene dichloride (300 ml) were cooled to 0-5° C.
  • Bromine (60 ml) was added to the mixture at 0-5° C. for 1 hour.
  • the contents were maintained for 4-5 hours at 25-30° C.
  • 10% NaHCO 3 (100 ml) solution was charged to the above mixture and stirred for 30 minutes.
  • the layers were separated.
  • Sodium carbonate (250 gms) and triethylamine (160 ml) were added in methylene dichloride layer and stirred at 25-30° C. for 1 hour.
  • the mixture was maintained for 2 hour at 25-30° C. and filtered. 20%.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a novel, industrially viable, cost effective process for the preparation of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide commonly known as Rufinamide and intermediates thereof.

Description

FIELD OF THE INVENTION
The invention provides a novel, industrially viable, cost effective process for manufacturing methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate a key intermediate in the synthesis of Rufinamide.
CROSS REFERENCE TO RELATED APPLICATION
This application is the complete specification and claims priority from the provisional specification No. 2458/CHE/2010 filed on Aug. 25, 2010
BACKGROUND OF THE INVENTION
1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide commonly known as Rufinamide (Formula I) is triazole derivative and is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children 4 years and older and adults. Rufinamide exerts its antiepileptic effect is unknown. The results of in vitro studies suggest that the principal mechanism of action of Rufinamide is modulation of the activity of sodium channels and in particular, prolongation of the inactive state of the channel. Rufinamide (≧1 μM) significantly slowed sodium channel recovery from inactivation after a prolonged prepulse in cultured cortical neurons, and limited sustained repetitive firing of sodium-dependent action potentials (EC50 of 3.8 μM).
Figure US08871945-20141028-C00001
The Rufinamide was first disclosed in U.S. Pat. No. 4,789,680 by Ciba-Geigy Corporation. The synthetic method employed is depicted in the following reaction scheme I.
Figure US08871945-20141028-C00002
The process comprises the preparation of Rufinamide by reacting 2,6-difluorobenzyl chloride and sodium azide in the presence of DMSO to obtain 2,6-difluoro benzyl azide, which is then treated with propiolic acid to give carboxylic acid intermediate which on further reaction with thionyl chloride to give corresponding acyl chloride. The acyl chloride intermediate is further reacted with methanolic ammonia to yield Rufinamide.
U.S. Pat. No. 6,277,999 describes the process for the preparation of Rufinamide as shown in Scheme II which comprises coupling of 2,6-difluorobenzyl azide and 2-chloroprop-2-enenitrile in presence of aq. sodium hydroxide and solvent toluene to give Rufinamide.
Figure US08871945-20141028-C00003
WO 2010/043849 describes the process for the preparation of Rufinamide as shown in scheme III below, which comprises the reaction of 2-(azidomethyl)-1, 3-difluorobenzene with methyl propiolate to obtain methyl 1-(2,6-difluorobenzyl)-1H-1,2,3,-triazole-4-carboxylate and which is reacted with ammonia to yield Rufinamide.
Figure US08871945-20141028-C00004
The aforementioned prior art processes involved expensive reagents like propiolic acid and 2-chloroprop-2-enenitrile in their processes and also the reported processes have complexities over yield, control of impurities like 5-carboxylic acid amide and tetrazole impurities during the process and commercial viability. Hence there is a continuous need for novel and effective process for preparing Rufinamide. The present inventors have made extensive researches to discover novel and commercially viable method for preparing Rufinamide with high yield.
SUMMARY OF THE INVENTION
A novel process for the preparation of Rufinamide and its intermediates has been developed. 1-(2, 6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate ester of formula VI, a key intermediate in the synthesis of Rufinamide is obtained by the reaction of 2-(azidomethyl)-1,3-difluorobenzyl with alkyl 2-bromoacrylate. The present invention also provides the process for the preparation of 2-bromoacrylate of formula V, which comprises brominating acrylate of formula IV in presence of a brominating agent followed by treatment with base.
The object of the invention is to provide a novel process for the preparation of Rufinamide.
Another object of the present invention is to provide a process for the preparation of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate ester of formula VI, a key intermediate in the preparation of Rufinamide.
Yet another object of the invention is to provide a process for the bromination of alkyl acrylate of formula IV to obtain alkyl 2-bromoacrylate of formula V which is being used in the present synthesis of Rufinamide.
DESCRIPTION OF THE INVENTION
In accordance with the present invention 1-(2,6-difluorobenzyl)-1H-1,2, 3-triazole-4-carboxylate ester of formula VI, a key intermediate in the synthesis of Rufinamide is obtained by the reaction of 2-(azidomethyl)-1,3- difluorobenzyl with alkyl 2-bromoacrylate. The process of the invention is depicted in following scheme-IV.
Figure US08871945-20141028-C00005
In the above scheme, 2-(azidomethyl)-1,3- difluorobenzyl of formula III
Figure US08871945-20141028-C00006

is obtained by reacting the 2-(halomethyl)-1,3-difluorobenzene of formula II, wherein X is Cl, Br or I with an alkali metal azide reagent. The alkali metal azide may be selected from sodium azide, potassium azide; preferably the alkali metal azide is sodium azide. The reaction is carried out in a polar solvent selected from the group consisting of DMSO, DMF, t-butanol, preferably t-butanol to give the compound of the formula III. In an embodiment, 2-(bromomethyl)-1,3-difluorobenzene is treated with sodium azide in t-butanol to obtain 2-(azidomethyl)-1,3- difluorobenzyl of formula III.
The condensation of the compound of formula III with 2-bromoacrylate of formula V to obtain compound of formula VI.
Figure US08871945-20141028-C00007
The invention relates in particular to the preparation of compound of formula VI in which R is hydrogen, methyl or ethyl by treating corresponding acrylates compound of formula V such as 2-bromoacrylic acid, methyl 2-bromoacrylate or ethyl 2-bromoacrylate with azide compound of formula III.
The invention relates primarily to the preparation of methyl 1-(2, 6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate of formula VI.
The condensation of the azide compound of formula III with formula V is carried out in suitable polar protic solvent selected from the group consisting of acetic acid, methanol, formic acid, isopropanol, water and the like and mixtures thereof. The said reaction is carried out preferably in water or tert-butanol or mixtures thereof to give the compound of the formula VI.
In a preferred embodiment 2-(azidomethyl)-1,3- difluorobenzene is treated with methyl 2-bromoacrylate in mixture of t-butanol and water to produce methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate.
The 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate ester, where R is C1-C6 alkyl, of formula VI can be directly converted to Rufinamide by treatment with ammonia or by other methods known in the prior art. The conversion can also be proceeded through 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylic acid intermediate, which in turn produced by hydrolysis of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate ester with alkali metal hydroxide.
In an preferred embodiment, methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate ester is hydrolysed in presence of aq. NaOH solution or NaOH flakes followed by acidification with HCl gives 1-(2,6-diflurobenzyl)-1H -1,2,3-triazole-4-carboxylic acid compound of formula VII.
Figure US08871945-20141028-C00008
Reaction of 1-(2,6-diflurobenzyl)-1H-1,2,3-triazole-4-carboxylic acid compound of formula VII, with chlorinating agents, preferably thionyl chloride, provides corresponding carbonyl chloride compound which is subsequently treated with ammonia to yield Rufinamide of formula I. The amidation reaction is done in presence of liquid or gaseous ammonia in a suitable solvent such as methanol, ethanol, propanol, toluene and the like and mixtures thereof; preferably toluene to give Rufinamide of formula I. The product is optionally purified from formic acid and methanol.
The present invention also provides process for the preparation of 2-bromoacrylate of formula V, which comprises brominating acrylate of formula IV in presence of a brominating agent followed by treatment with base.
Figure US08871945-20141028-C00009
The invention relates in particular to the preparation of compound of formula V in which R is hydrogen, methyl or ethyl by brominating acrylic acid, methyl acrylate or ethyl acrylate of formula IV in presence of brominating agent. The invention relates primarily to the preparation of compound of formula V in which R is methyl by brominating methyl acrylate.
The bromination reaction can be carried out in presence of a reagent selected from the group consisting of phosphorus tribromide, aluminum tribromide, bromine and the like; in suitable aprotic solvent selected from the group consisting of THF, acetone, acetonitrile and MDC and the like. The base used in the bromination reaction is selected from the group consisting of sodium bicarbonate, potassium carbonate, potassium bicarbonate, potassium tert-butoxide, triethyl amine; preferably sodium carbonate and triethylamine, to give compound of the formula V. In a preferred embodiment methyl acrylate is brominated in presence of bromine and sodium carbonate in methylene chloride solvent to produce methyl 2-bromoacrylate.
The invention is further illustrated with following non-limiting examples:
EXAMPLES Example-1 Preparation of Monobromo Methyl Acrylate
A mixture of Methyl acrylate (100 g) and methylene dichloride (300 ml) were cooled to 0-5° C. Bromine (60 ml) was added to the mixture at 0-5° C. for 1 hour. The contents were maintained for 4-5 hours at 25-30° C. 10% NaHCO3 (100 ml) solution was charged to the above mixture and stirred for 30 minutes. The layers were separated. Sodium carbonate (250 gms) and triethylamine (160 ml) were added in methylene dichloride layer and stirred at 25-30° C. for 1 hour. The mixture was maintained for 2 hour at 25-30° C. and filtered. 20%. HCl solution (100 ml) was charged into filtrate and stirred for 30 minutes. The layer was separated and the organic layer was washed with 20% HCl solution (100 ml). The organic layer was distilled off completely under vacuum at below 30° C. Yield: 140 gms.
Example-2 Preparation of 2-(azidomethyl)-1,3-difluorobenzene
A mixture of 2,6-diflourobenzyl bromide (100 gms), tetrabutylammonium bromide (10 gms), t-butanol (200 ml) and sodium azide (62.8 gm) were stirred at room temperature for 22-24 hours. After the completion, reaction mass was filtered and washed with t-butanol (2.5 ml ) to give 2-(azidomethyl)-1,3-difluorobenzene.
Example-3 Preparation of methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole -4-carboxylate
A mixture of 2-(azidomethyl)-1,3-difluorobenzene in t-butanol prepared as per example 2, methyl 2-bromoacrylate (120 gms) and water (200 ml) were heated to 75-80° C. The contents was stirred at 75-80° C. for 24 hours. After the completion of reaction, the reaction mixture was cooled to room temperature. The solid obtained was filtered and then crude mass was added to cyclohexane (240 ml) and the mixture was stirred at room temperature for 2 hours. The solid was filtered and washed with cyclohexane (50 ml). The product was dried for 2 hours to give methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate. Yield: 120 gms
Example-4 Preparation of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylic acid
A mixture of Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate. (50 gms) and a solution of sodium hydroxide (11.76 gms in 100 ml water) were stirred at room temperature contents till it becomes clear. Hydrochloric acid (30 ml ) in DM water (70 ml) was charged to above reaction mass. Adjusted the PH of the reaction till 2-3 by adding the hydrochloric acid solution at 25-30° C. After the completion, reaction mass was filtered and dried the material at 65° C.-70° C. for 15 hours. Yield: 40 gms
Example 5 Preparation of Rufinamide
A mixture of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylic acid (25 gms) and thionyl chloride (63.5 gms) were stirred at 80° C. and maintained for 3 hours. The reaction mass was cooled to 50° C. and excess thionyl chloride was distilled off. To this reaction mass toluene (25 ml) was charged twice and it was distilled off under vacuum it was followed by addition of toulene (175 ml) to get clear solution. Aqueous ammonia (100 ml) charged into reaction mass at room temperature and maintained for 2 hours. The reaction mass was filtered. 10% sodium carbonate solution was added to above solid and stirred for 30 minutes. The solid was filtered and washed with water and cyclohexane (50 ml). Dried the crude material in a vacuum oven at 70-80° C. for 10 hours. Yield: 23.00 gm.
Example 6 Purification of Rufinamide
Crude Rufinamide (7.5 gm) and formic acid (36 ml ) were heated to 50-55° C. to get a clear solution. It was added to methanol over 2 hours at 20-25° C. Methanol (37.5 ml) was added to the reaction mass at 20-25° C. After addition the reaction mass was stirred for 2 hours at 20-25° C. The solid was filtered and washed with methanol (75 ml ). The solid was dried at 60° C. under vacuum. Yield: 6.3 gms.

Claims (13)

We claim:
1. A process for preparing Rufinamide of formula I
Figure US08871945-20141028-C00010
comprising the steps of:
(a) reacting a compound of formula III
Figure US08871945-20141028-C00011
with 2-bromoacrylate of formula V to obtain a compound of formula VI
Figure US08871945-20141028-C00012
Figure US08871945-20141028-C00013
wherein R is hydrogen or a C1-C6 alkyl group; and
(b) converting the compound of formula VI to Rufinamide of formula I.
2. The process according to claim 1, wherein R is hydrogen, methyl or ethyl.
3. The process according to claim 1, wherein the compound of formula V is selected from 2-bromoacrylic acid, methyl 2-bromoacrylate and ethyl 2-bromoacrylate.
4. The process according to claim 1, wherein the compound of formula VI prepared in step (a) is methyl 1-(2, 6-difluorobenzyl)-1H-1, 2, 3-triazole-4-carboxylate.
5. The process according to claim 1 wherein the compound of formula V is prepared by a method comprising the steps of:
Br
Formula—V
brominating a compound of formula IV in the presence of a brominating agent followed by treatment with base,
Figure US08871945-20141028-C00014
wherein the R group of formula IV is hydrogen or C1-C6alkyl group.
6. The process according to claim 5, wherein R is H, methyl or ethyl.
7. The process according to claim 6, wherein R is methyl.
8. The process according to claim 5, wherein the brominating agent is selected from the group consisting of phosphorus tribromide, aluminum tribromide and bromine.
9. The process according to claim 8, wherein the brominating agent is bromine.
10. The process according to claim 5, wherein the base is selected from the group consisting of sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, potassium t-butoxide and triethylamine.
11. The process according to claim 10, wherein the base is selected from sodium carbonate and triethylamine.
12. The process according to claim 5, wherein methyl 2-bromoacrylate is prepared.
13. The process of claim 1, further comprising the step of purifying the Rufinamide obtained in step (b).
US13/818,660 2010-08-25 2011-08-23 Process for preparation of rufinamide Expired - Fee Related US8871945B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2458CH2010 2010-08-25
IN2458/CHE/2010 2010-08-25
PCT/IN2011/000561 WO2012025936A2 (en) 2010-08-25 2011-08-23 Improved process for the preparation of rufinamide

Publications (2)

Publication Number Publication Date
US20130184469A1 US20130184469A1 (en) 2013-07-18
US8871945B2 true US8871945B2 (en) 2014-10-28

Family

ID=45723872

Family Applications (1)

Application Number Title Priority Date Filing Date
US13/818,660 Expired - Fee Related US8871945B2 (en) 2010-08-25 2011-08-23 Process for preparation of rufinamide

Country Status (5)

Country Link
US (1) US8871945B2 (en)
EP (1) EP2640711B1 (en)
JP (1) JP6108112B2 (en)
PL (1) PL2640711T3 (en)
WO (1) WO2012025936A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9511151B2 (en) 2010-11-12 2016-12-06 Uti Limited Partnership Compositions and methods for the prevention and treatment of cancer
US10988516B2 (en) 2012-03-26 2021-04-27 Uti Limited Partnership Methods and compositions for treating inflammation
CN103539750A (en) * 2012-07-09 2014-01-29 旭和(天津)医药科技有限公司 Synthesis process of rufinamide
US9603948B2 (en) 2012-10-11 2017-03-28 Uti Limited Partnership Methods and compositions for treating multiple sclerosis and related disorders
WO2014072992A1 (en) 2012-11-12 2014-05-15 Aarti Industries Limited A process for preparing triazole compounds
WO2014121383A1 (en) * 2013-02-11 2014-08-14 Apotex Technologies Inc. A process for the preparation of rufinamide and intermediates thereof
US10124045B2 (en) 2013-11-04 2018-11-13 Uti Limited Partnership Methods and compositions for sustained immunotherapy
CN109096211B (en) * 2018-08-30 2021-11-23 华侨大学 Preparation method of polysubstituted triazole derivative
CN114106211A (en) * 2021-08-31 2022-03-01 海南医学院 Yunnan chanterelle polysaccharide and separation and purification method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130045998A1 (en) * 2010-04-30 2013-02-21 Laboratorios Lesvi, S.L. Process for preparing rufinamide intermediate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1030332B (en) * 1955-11-09 1958-05-22 Basf Ag Process for the production of ª ‡ -chloroacrylic acid esters
JPS596305B2 (en) * 1980-03-11 1984-02-10 工業技術院長 Method for producing 1,2,3-triazole derivatives
US4789680A (en) 1982-12-23 1988-12-06 Ciba-Geigy Corporation Aralkyltriazole compounds
WO1998002423A1 (en) * 1996-07-11 1998-01-22 Novartis Ag Process for preparing 1-substituted 4-cyano-1,2,3-triazoles
US8183269B2 (en) * 2008-10-13 2012-05-22 Cipla Limited Process for the preparation of rufinamide

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130045998A1 (en) * 2010-04-30 2013-02-21 Laboratorios Lesvi, S.L. Process for preparing rufinamide intermediate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Mudd, Apr. 18, 2010, Tetrahedron Letters, vol. 51, p. 3229-3231. *

Also Published As

Publication number Publication date
JP6108112B2 (en) 2017-04-05
US20130184469A1 (en) 2013-07-18
WO2012025936A2 (en) 2012-03-01
PL2640711T3 (en) 2016-06-30
JP2013538208A (en) 2013-10-10
EP2640711A4 (en) 2014-02-12
WO2012025936A3 (en) 2012-04-19
EP2640711B1 (en) 2015-10-14
EP2640711A2 (en) 2013-09-25

Similar Documents

Publication Publication Date Title
US8871945B2 (en) Process for preparation of rufinamide
US8076492B2 (en) Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil
US8183269B2 (en) Process for the preparation of rufinamide
US9096570B2 (en) Process for manufacturing substituted 3-pyridylmethyl ammonium bromides
US10626091B2 (en) Process for the preparation of enzalutamide
KR20170029506A (en) Process for the preparation of 4-alkoxy-3-hydroxypicolinic acids
US7964737B2 (en) Process for producing 2-(n-butyl)-3-[[2′-(tetrazol-5-yl)biphenyl-4-yl]methyl]-1,3-diazaspiro[4.4] non-1-en-4-one
US20070093540A1 (en) process for the preparation of angiotensin ii antagonistic compounds
US20240067624A1 (en) Process for preparation of insecticidal anthranilamides
US8957252B2 (en) Process for preparation of lacosamide and some N-benzyl-propanamide intermediate derivatives
US20090286989A1 (en) Process for High Purity Anastrozole
US20140343290A1 (en) Process for the preparation of atazanavir or its bisulfate salt
JP5816704B2 (en) Process for obtaining compounds derived from tetrahydro-β-carboline
WO2012032540A1 (en) Process for preparation of fluorinated triazole compound
US20220340532A1 (en) Processes for the preparation of roxadustat and intermediates thereof
WO2004058681A1 (en) Process for producing benzylamine derivative
NO318467B1 (en) Process for the preparation of 1,5-diaryl-3-substituted pyrazoles
JPH06166666A (en) Hydrazone derivative and its production
US20070149606A1 (en) Process for producing phenylacetic acid derivative
WO2011045807A2 (en) A novel process to manufacture (2r,3s)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol
JPWO2004035529A1 (en) Process for producing N- (2-amino-1,2-dicyanovinyl) formamidine
JPH06298684A (en) Production of new 4-(2-substituted)-phenylbenzyl bromide
WO2004041830A2 (en) An improved process for the preparation of biotin
US20180208544A1 (en) An improved process for the preparation of baclofen and its intermediate
JPH07126254A (en) Imidazole compound and its production

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.)

LAPS Lapse for failure to pay maintenance fees

Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Expired due to failure to pay maintenance fee

Effective date: 20181028